Cryomed works with warmer temperatures:
This article was originally published in Clinica
Executive Summary
Haifa based Cryomed has developed a new method for hypothermic treatment of human tissue. The technique uses a cryogen in an insulated vessel - heat is absorbed during melting, freezing the tissue. Cryomed says that the advantages of this system compared with devices currently on the market are that the cryogens do not need to be replaced; there is no limit to the inclination angle; and the relatively moderate temperatures used mean that target tissue can be repeatedly frozen and thawed with minimal collateral damage.
You may also be interested in...
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.